Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes

The hepatitis B virus (HBV) infection is a major risk factor for cirrhosis and hepatocellular carcinoma. Most infected individuals become lifelong carriers of HBV as the drugs currently used to treat the patients can only control the disease, thereby achieving functional cure (loss of the hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chien-Jung, Wang, Lily Hui-Ching, Wang, Yu-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307716/
https://www.ncbi.nlm.nih.gov/pubmed/34357116
http://dx.doi.org/10.3390/jpm11070649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307716/
https://www.ncbi.nlm.nih.gov/pubmed/34357116
http://dx.doi.org/10.3390/jpm11070649

Ejemplares similares